Kati Hasenbein

No ORCID on file · 4 papers in corpus · active 2011-2022

Study types

  • article 3
  • letter 1

Condition tags

  • endometriosis 4
  • bowel_endometriosis 1
  • die_deep_infiltrating 1
article 2022
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients
BMC cancer ·doi:10.1186/s12885-022-09887-5

BACKGROUND: To evaluate the diagnostic value of adding human epididymis protein 4 (HE4), cancer antigen 125 (CA125) and risk of malignancy algorithm (ROMA) to ultrasound for detecting ovarian cancer in patients with a pelvic mass. METHODS: …

article 2018
HE4 is the marker of choice in discriminating endometriosis from ovarian cancer in pelvic mass patients: Sub-analysis of a prospective multicentric study
·doi:10.1016/j.ygyno.2018.04.547
article 2015
Direct cost of deep infiltrating endometriosis surgically treated in a German referral center
·doi:10.1055/s-0035-1558379

Deep infiltrating endometriosis (DIE) is a complex disease, leading to diverse symptoms in affected women of reproductive age. This retrospective study aimed to describe patient characteristics and to calculate the direct costs during inpat…

letter 2011
Rectovaginal Endometriosis
Annals of surgery ·doi:10.1097/sla.0b013e31822ace9b

Mangler, Mandy MD; Hasenbein, Kati MD; Bartley, Julia MD; Lanowska, Malgorzata MD; Schneider, Achim MD, MPH; Köhler, Christhardt MD Author Information